Efficacy and Safety of Once-Weekly Semaglutide Monotherapy Versus Placebo in Patients With Type 2 Diabetes (SUSTAIN 1): A Double-Blind, Randomised, Placebo-Controlled, Parallel-Group, Multinational, Multicentre Phase 3a Trial
resM GLP-1 Postbiotic offers a range of benefits to distinguish itself from others on the market, including: Enhanced GLP-1 levels and metabolism Weight management support Reduced cravings Healthy blood sugar balance " With the rise in awareness surrounding gut health and its significant impact on overall wellbeing, the team at res recognized the need for a product that supports both digestion and metabolism in a clinically effective manner ," said Dr
aeruginosa 73
Our latest article focuses on two innovative weight loss solutions, Mounjaro and Wegovy, specifically designed GLP-1 medications
If efficacy is lower, oral semaglutide's established track record makes it the safer choice